Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1964 1
1971 1
1972 2
1973 2
1974 1
1975 23
1976 24
1977 24
1978 23
1979 23
1980 56
1981 93
1982 106
1983 114
1984 102
1985 110
1986 112
1987 122
1988 134
1989 156
1990 143
1991 145
1992 171
1993 198
1994 206
1995 225
1996 213
1997 231
1998 259
1999 278
2000 317
2001 309
2002 355
2003 462
2004 451
2005 488
2006 510
2007 496
2008 573
2009 601
2010 710
2011 764
2012 846
2013 927
2014 922
2015 975
2016 606
2017 500
2018 766
2019 789
2020 830
2021 875
2022 827
2023 656
2024 150

Text availability

Article attribute

Article type

Publication date

Search Results

17,011 results

Results by year

Filters applied: . Clear all
Page 1
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma.
Kristensen NP, Heeke C, Tvingsholm SA, Borch A, Draghi A, Crowther MD, Carri I, Munk KK, Holm JS, Bjerregaard AM, Bentzen AK, Marquard AM, Szallasi Z, McGranahan N, Andersen R, Nielsen M, Jönsson GB, Donia M, Svane IM, Hadrup SR. Kristensen NP, et al. Among authors: andersen r. J Clin Invest. 2022 Jan 18;132(2):e150535. doi: 10.1172/JCI150535. J Clin Invest. 2022. PMID: 34813506 Free PMC article. Clinical Trial.
Moreover, we found that the frequency of neoepitope-specific CD8+ T cells in TIL infusion products correlated with increased survival and that neoepitope-specific CD8+ T cells shared with the infusion product in posttreatment blood samples were unique to responders …
Moreover, we found that the frequency of neoepitope-specific CD8+ T cells in TIL infusion products correlated with increased survival …
Anti-regulatory T cells.
Andersen MH. Andersen MH. Semin Immunopathol. 2017 Apr;39(3):317-326. doi: 10.1007/s00281-016-0593-x. Epub 2016 Sep 27. Semin Immunopathol. 2017. PMID: 27677755 Review.
Our initial understanding of immune-regulatory cells was based on the discovery of suppressor cells that assure peripheral T-cell tolerance and promote immune homeostasis. Research has particularly focused on the importance of regulatory T cells (Tregs) for immune m …
Our initial understanding of immune-regulatory cells was based on the discovery of suppressor cells that assure peripheral T-cell tol …
PD-L1-specific T cells.
Ahmad SM, Borch TH, Hansen M, Andersen MH. Ahmad SM, et al. Among authors: andersen mh. Cancer Immunol Immunother. 2016 Jul;65(7):797-804. doi: 10.1007/s00262-015-1783-4. Epub 2016 Jan 2. Cancer Immunol Immunother. 2016. PMID: 26724936 Free PMC article. Review.
Thus, PD-L1-specific T cells have the ability to modulate adaptive immune reactions by reacting to regulatory cells. ...This review summarizes present information about PD-L1 as a T cell antigen, depicts the initial findings about the function of PD-L1-specific T …
Thus, PD-L1-specific T cells have the ability to modulate adaptive immune reactions by reacting to regulatory cells. ...This review s …
The T-win technology: immune-modulating vaccines.
Andersen MH. Andersen MH. Semin Immunopathol. 2019 Jan;41(1):87-95. doi: 10.1007/s00281-018-0695-8. Epub 2018 Jul 2. Semin Immunopathol. 2019. PMID: 29968045 Review.
The T-win technology is an innovative investigational approach designed to activate the body's endogenous anti-regulatory T cells (anti-Tregs) to target regulatory as well as malignant cells. ...Because T-win technology is based on the immune-modulatory funct …
The T-win technology is an innovative investigational approach designed to activate the body's endogenous anti-regulatory T ce …
Characterization of circulating T-, NK-, and NKT cell subsets in patients with colorectal cancer: the peripheral blood immune cell profile.
Krijgsman D, de Vries NL, Skovbo A, Andersen MN, Swets M, Bastiaannet E, Vahrmeijer AL, van de Velde CJH, Heemskerk MHM, Hokland M, Kuppen PJK. Krijgsman D, et al. Among authors: andersen mn. Cancer Immunol Immunother. 2019 Jun;68(6):1011-1024. doi: 10.1007/s00262-019-02343-7. Epub 2019 May 3. Cancer Immunol Immunother. 2019. PMID: 31053876 Free PMC article.
OBJECTIVE: As the development and progression of colorectal cancer (CRC) are known to be affected by the immune system, cell subsets such as T cells, natural killer (NK) cells, and natural killer T (NKT) cells are considered interesting targets for immunotherapy and …
OBJECTIVE: As the development and progression of colorectal cancer (CRC) are known to be affected by the immune system, cell subsets such as …
FOXP3-specific immunity.
Andersen MH. Andersen MH. Oncoimmunology. 2013 Oct 1;2(10):e26247. doi: 10.4161/onci.26247. Epub 2013 Sep 12. Oncoimmunology. 2013. PMID: 24498544 Free PMC article.
Forkhead box P3 (FOXP3)-specific cytotoxic CD8(+) T cells are present among human peripheral blood mononuclear cells (PBMCs), especially in cancer patients. Such T lymphocytes are able not only to specifically recognize dendritic cells (DCs) that have been exposed t …
Forkhead box P3 (FOXP3)-specific cytotoxic CD8(+) T cells are present among human peripheral blood mononuclear cells (PBMCs), especia …
Pediatric acute myeloid leukemia with t(7;21)(p22;q22).
Paulraj P, Diamond S, Razzaqi F, Ozeran JD, Longhurst M, Andersen EF, Toydemir RM, Hong B. Paulraj P, et al. Among authors: andersen ef. Genes Chromosomes Cancer. 2019 Aug;58(8):551-557. doi: 10.1002/gcc.22740. Epub 2019 Feb 14. Genes Chromosomes Cancer. 2019. PMID: 30706625 Review.
The t(7;21)(p22;q22) resulting in RUNX1-USP42 fusion, is a rare but recurrent cytogenetic abnormality associated with acute myeloid leukemia (AML) and myelodysplastic syndromes. ...One patient had t(7;21)(p22;q22) as the sole abnormality, whereas the other two patie …
The t(7;21)(p22;q22) resulting in RUNX1-USP42 fusion, is a rare but recurrent cytogenetic abnormality associated with acute myeloid l …
The role of dendritic cells in cancer.
Hansen M, Andersen MH. Hansen M, et al. Among authors: andersen mh. Semin Immunopathol. 2017 Apr;39(3):307-316. doi: 10.1007/s00281-016-0592-y. Epub 2016 Sep 16. Semin Immunopathol. 2017. PMID: 27638181 Review.
Though present in low numbers, dendritic cells (DCs) are recognized as major players in the control of cancer by adaptive immunity. The roles of cytotoxic CD8(+) T-cells and Th1 helper CD4(+) T-cells are well-documented in murine models of cancer and associated with …
Though present in low numbers, dendritic cells (DCs) are recognized as major players in the control of cancer by adaptive immunity. The role …
Immunoregulatory antigens-novel targets for cancer immunotherapy.
Pedersen AW, Kopp KL, Andersen MH, Zocca MB. Pedersen AW, et al. Among authors: andersen mh. Chin Clin Oncol. 2018 Apr;7(2):19. doi: 10.21037/cco.2018.01.03. Chin Clin Oncol. 2018. PMID: 29764164 Free article. Review.
Here we discuss a novel approach to cancer immunotherapy, namely to target recently described T cells that uniquely control cells with immune suppressive functions. ...Vaccination approaches to potentiate these T cells have proven safe with minimal toxicity in the c …
Here we discuss a novel approach to cancer immunotherapy, namely to target recently described T cells that uniquely control cells wit …
Cytotoxic T cells.
Andersen MH, Schrama D, Thor Straten P, Becker JC. Andersen MH, et al. J Invest Dermatol. 2006 Jan;126(1):32-41. doi: 10.1038/sj.jid.5700001. J Invest Dermatol. 2006. PMID: 16417215 Free article. Review.
T lymphocytes arise in the bone marrow and migrate to the thymus for maturation. During this process, T cells somatically rearrange gene segments, eventually leading to the expression of a unique antigen-binding molecule, the T-cell receptor (TCR). ...
T lymphocytes arise in the bone marrow and migrate to the thymus for maturation. During this process, T cells somatically rear …
17,011 results
You have reached the last available page of results. Please see the User Guide for more information.